JP2017500567A5 - - Google Patents

Download PDF

Info

Publication number
JP2017500567A5
JP2017500567A5 JP2016541152A JP2016541152A JP2017500567A5 JP 2017500567 A5 JP2017500567 A5 JP 2017500567A5 JP 2016541152 A JP2016541152 A JP 2016541152A JP 2016541152 A JP2016541152 A JP 2016541152A JP 2017500567 A5 JP2017500567 A5 JP 2017500567A5
Authority
JP
Japan
Prior art keywords
levels
acid
biomarker
level
dnl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016541152A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017500567A (ja
JP6557235B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/071035 external-priority patent/WO2015095451A1/en
Publication of JP2017500567A publication Critical patent/JP2017500567A/ja
Publication of JP2017500567A5 publication Critical patent/JP2017500567A5/ja
Application granted granted Critical
Publication of JP6557235B2 publication Critical patent/JP6557235B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016541152A 2013-12-20 2014-12-18 de novo脂質生成のバイオマーカーおよびその使用方法 Active JP6557235B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361918866P 2013-12-20 2013-12-20
US61/918,866 2013-12-20
US201461934033P 2014-01-31 2014-01-31
US61/934,033 2014-01-31
PCT/US2014/071035 WO2015095451A1 (en) 2013-12-20 2014-12-18 Biomakers of de novo lipogenesis and methods using the same

Publications (3)

Publication Number Publication Date
JP2017500567A JP2017500567A (ja) 2017-01-05
JP2017500567A5 true JP2017500567A5 (enExample) 2018-02-01
JP6557235B2 JP6557235B2 (ja) 2019-08-07

Family

ID=53403674

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016541152A Active JP6557235B2 (ja) 2013-12-20 2014-12-18 de novo脂質生成のバイオマーカーおよびその使用方法

Country Status (9)

Country Link
US (1) US20160356798A1 (enExample)
EP (1) EP3082833B1 (enExample)
JP (1) JP6557235B2 (enExample)
AU (1) AU2014364539B2 (enExample)
CA (1) CA2933571A1 (enExample)
ES (1) ES2708807T3 (enExample)
MX (1) MX2016008045A (enExample)
SG (1) SG11201604702YA (enExample)
WO (1) WO2015095451A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105400732A (zh) * 2015-11-19 2016-03-16 南京理工大学 一种酒精性脂肪肝斑马鱼模型的构建方法
EP3468530A4 (en) 2016-06-10 2020-03-11 Clarity Cosmetics Inc. NON-COMEDOGEN FORMULA FOR HAIR AND SCALP CARE AND METHOD FOR USE
GB201614455D0 (en) 2016-08-24 2016-10-05 Univ Oxford Innovation Ltd Biomarkers
US11709169B2 (en) * 2017-02-07 2023-07-25 National Jewish Health Lipid abnormalities and association with atopic allergic diseases
WO2018183448A1 (en) * 2017-03-31 2018-10-04 Metabolon, Inc. Comprehensive and quatitative lipid and tocopherol analysis
US11642300B2 (en) 2019-05-15 2023-05-09 Johnson & Johnson Consumer Inc. Method of selecting skin treatment regimens, ingredients and compositions
US20220142560A1 (en) 2020-11-06 2022-05-12 Johnson & Johnson Consumer Inc. Microbiome and metobolome clusters to evaluate skin health

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1438420B1 (en) * 2001-09-24 2009-09-16 Lipomics Technologies, Inc. Methods of using quantitative lipid metabolome data
WO2005109006A1 (ja) * 2004-04-23 2005-11-17 Ajinomoto Co., Inc. 非アルコール性脂肪肝炎鑑別方法
US8119358B2 (en) * 2005-10-11 2012-02-21 Tethys Bioscience, Inc. Diabetes-related biomarkers and methods of use thereof
BRPI0810409A2 (pt) * 2007-04-18 2015-02-18 Thethys Bioscience Inc Biomarcadores relacionados ao diabetes e métodos de uso destes
WO2010028336A2 (en) * 2008-09-08 2010-03-11 President And Fellows Of Harvard College Fatty acid c16:1n7-palmitoleate a lipokine and biomarker for metabolic status
WO2012040318A2 (en) * 2010-09-23 2012-03-29 University Of Miami Compositions, methods and kits for detecting melanoma and margins of melanoma

Similar Documents

Publication Publication Date Title
Hodson et al. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake
Harris et al. Red blood cell fatty acid levels improve GRACE score prediction of 2-yr mortality in patients with myocardial infarction
Ilias et al. Adipose tissue lipolysis and circulating lipids in acute and subacute critical illness: effects of shock and treatment
Ozay et al. The role of oxidative stress and inflammatory response in high-fat diet induced peripheral neuropathy
JP6557235B2 (ja) de novo脂質生成のバイオマーカーおよびその使用方法
Lulzim Discriminant analysis of morphologic and motor parameters of athlete and non athlete girl pupils of primary school on age 14 to 15 years.
Coates et al. Cardiac remodeling in elite aquatic sport athletes
CN111370066A (zh) 一种利用斑马鱼评估离子液体对脂代谢影响的方法
RU2009117008A (ru) Способ диагностики бронхиальной астмы у детей раннего возраста с использованием данных цитологии индуцированной мокроты
Hodson et al. Micro-techniques for analysis of human adipose tissue fatty acid composition in dietary studies
Song et al. Viscoelastic Characteristics in Mouse Model of Hepatic Steatosis With Inflammation by Kelvin–Voigt Fractional Derivative Modeling
CN203732398U (zh) 粪便粘度测定装置
Franzen Item difficulty
Rosic et al. Mathematical analysis of the heart rate performance curve during incremental exercise testing
Biben et al. Prevalence of Metabolic Syndrome Risk Factors in College-Aged Students
Mickle et al. Reliability of ultrasound to measure morphology of the toe flexor muscles
Kawasumi et al. New criteria of hyperlipidemia with insulin resistance in dogs
So et al. Irisin is associated with physical activity level and hepatic steatosis grade in non-alcoholic fatty liver disease subjects: 841
Vuppalanchi et al. Is liver stiffness measurement (LSM) by Fibroscan better than FIB4 score for prediction of clinically significant fibrosis in patients with NAFLD?: 842
Minzaghi et al. 214 Topical DEHP exposure leads to inflammation and epidermal barrier damage in epidermal equivalents
Velthuijs et al. 215 Spatial transcriptomics on human epidermal equivalents
Cavallo et al. 217 Distinctive and shared signatures of Th1 and Th2 cytokines on the lipid pathways involved in the epidermal barrier function
Samoilova et al. Features of the mobile pool of fatty acids (lipoproteins and free fatty acids) in adolescents with different body weights
RU2015122704A (ru) Способы определения кетогенности метаболизма животного
Mohiee El Deen Abdel Aziz et al. Evaluation of serum connective tissue growth factor [CTGF] as a new noninvasive marker for assessment of hepatic fibrogenesis in children with chronic liver diseases